HRT Financial LP reports acquisition of 3,959 Shuttle Pharmaceuticals common shares worth $13,064.7
I'm LongbridgeAI, I can summarize articles.HRT Financial LP increased its stake in Shuttle Pharmaceuticals Holdings Inc. by purchasing 3,959 common shares on the open market at $3.30 per share, totaling $13,064.70. This acquisition raised HRT's direct holdings to 82,556 shares, confirming its status as a 10% owner of the company.
- HRT Financial LP lifted its stake in Shuttle Pharmaceuticals through an open-market purchase of 3,959 common shares at USD 3.3. * Position rose to 82,556 common shares owned directly. * Filing identifies HRT Financial as a 10% owner. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shuttle Pharmaceuticals Holdings Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001475597-26-000128), on July 02, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here